TGFBR1 inhibition for GATA4-deficient lung cancer

DISEASE CATEGORY: Cancer

INDICATION: Non-small cell lung cancer (NSCLC)

Cell culture and mouse studies suggest inhibiting TGFBR1 could help treat GATA4-deficient NSCLC. In a human

Read the full 239 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE